Drug
Candesartan clinical trials
Also written Blopress.
- studies test it
- 67
- open now
- 3
- in phase 3
- 17
- first study started
- 1998
Keep track of what changes. Save the candesartan studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Studies by the year they started
64 studies that test it; most in 2006 (9)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 1999 | 3 |
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 9 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 3
- Phase 1
- 13
- Phase 2
- 13
- Phase 3
- 17
- Phase 4
- 19
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 26 · Other 41
AstraZeneca (8) · Chong Kun Dang Pharmaceutical (7) · Emory University (2) · Mayo Clinic (2) · Medical University of Vienna (2) · Vanderbilt University (2) · Takeda (2) · EMS (2)
Often tested with
Tested in the same studies.
Ramipril (5) · Amlodipine (4) · Lisinopril (3) · Valsartan (3) · Hydrochlorothiazide (3) · Enalapril (3) · Nifedipine (2) · Metoprolol (2)
Studies
Open first, then newest update. How each study uses candesartan is read from its arms, and is right about nine times in ten.
Testing it · 67
- To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary HypercholesterolemiaEnrolling by invitationPhase 3Hyundai PharmNCT06646354Written as Ezetimibe/Rosuvastatin/Candesartan/Amlodipine
- Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)RecruitingPhase 3Cristina Avendaño SoláNCT05321875Written as Candesartan
- Effect of Some Drugs on Liver FibrosisRecruitingPhase 3Sherief Abd-ElsalamNCT03770936Written as Candesartan
- Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy SubjectsCompletedPhase 1Tanabe Pharma CorporationNCT01976572Written as candesartan
- Candesartan for Migraine Prevention:CompletedPhase 2St. Olavs HospitalNCT04574713Written as Candesartan Oral Tablet 8 mg
- Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedPhase 1HanAll BioPharma Co., Ltd.NCT02988362Written as Candesartan 16mg and Amlodipine 10mg
- Adiposity and Endothelin Receptor FunctionActive, not recruitingEarly Phase 1Augusta UniversityNCT03583866Written as Candesartan
- Candesartan's Effects on Alzheimer's Disease And Related BiomarkersCompletedPhase 2Emory UniversityNCT02646982Written as Candesartan
- Candesartan as an Adjunctive Treatment for Bipolar DepressionWithdrawnEarly Phase 1The University of Texas Health Science Center, HoustonNCT04430959Written as Candesartan
- An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine DependenceCompletedPhase 1Baylor College of MedicineNCT01062451Written as Candesartan
- CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral FunctionCompletedPhase 1/2Mayo ClinicNCT01678794Written as Candesartan
- Candesartan in Peripheral NeuropathyTerminatedPhase 2University Hospital, LimogesNCT03688633Written as Candesartan
- Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)Status unknownPhase 2/3Medical University of ViennaNCT04351724Written as Candesartan
- CAndesartan vs LIsinopril Effects on the BRainCompletedPhase 2Emory UniversityNCT01984164Written as Candesartan
- Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast CancerStatus unknownNot applicableSamsung Medical CenterNCT04429633Written as Candesartan
- Drug-drug-interaction Study of Candesartan, Amlodipine and AtorvastatinCompletedPhase 1Midas Pharma GmbHNCT04245046Written as Candesartan, Amlodipine, Atorvastatin
- Efficacy and Safety of Candesartan Associated With Chlorthalidone Versus Losartan Associated With Hydrochlorothiazide (Hyzaar®) in Essential Hypertension ControlWithdrawnPhase 3EMSNCT02521246Written as Candesartan + Chlorthalidone
- Efficacy and Safety of Candesartan Associated With Chlorthalidone in Essential Arterial Hypertension ControlWithdrawnPhase 3EMSNCT02521233Written as Candesartan + Chlorthalidone (8mg+12,5mg)
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus HydrochlorothiazideCompletedPhase 3NovartisNCT00360178Written as Candesartan plus Hydrochlorothiazide
- Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life DepressionTerminatedPhase 4Vanderbilt UniversityNCT01794455Written as Candesartan
See all 67 studies that test candesartan →
Given in every arm · 3 — candesartan is usual care beside what is tested
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedPhase 3University of British ColumbiaNCT04606563Written as Candesartan
- Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCompletedPhase 3Chong Kun Dang PharmaceuticalNCT02651870Written as Candesartan 16mg
- Investigate a Pharmacokinetic Characteristics and the Safety of AG1502 in Healthy Male SubjectsStatus unknownPhase 1Ahn-Gook Pharmaceuticals Co.,LtdNCT02614352Written as Atorvastatin + Candesartan
As the comparator · 8 — what is tested is compared with candesartan
- SPIRO-First: A Pragmatic Primary Care-Embedded Pilot Trial of Renin-Guided First-Line Antihypertensive TherapyNot yet recruitingPhase 4Ottawa Hospital Research InstituteNCT07687160Written as Candesartan 8mg
- Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)Not yet recruitingPhase 4Stanford UniversityNCT07655440Written as Candesartan
- Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for HypertensionCompletedPhase 2Washington University School of MedicineNCT03640312Written as Candesartan
- Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential HypertensionCompletedPhase 2Shin Poong Pharmaceutical Co. Ltd.NCT06212648Written as SPC3001
- Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each MonotherapyCompletedPhase 3Alvogen KoreaNCT02770261Written as Candesartan32mg
- Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate DrugsCompletedPhase 1Chong Kun Dang PharmaceuticalNCT02548286Written as Candesartan 8mg
- Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy VolunteersCompletedPhase 4Boehringer IngelheimNCT02261116Written as Candesartan
- Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate HypertensionStatus unknownPhase 3University of PaviaNCT00644475Written as Candesartan
Codes
What other systems call candesartan · ClinicalTrials.gg INT003731
- MeSH (NLM) C081643candesartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S8Q36MD2XXCANDESARTANConfirmed FDA, NLM, Wikidata
- RxNorm 214354Confirmed FDA, Wikidata
- Wikidata Q415970candesartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65284CandesartanOne source FDA
- DrugBank DB13919One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C081643 | candesartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S8Q36MD2XX | CANDESARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 214354 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415970 | candesartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65284 | Candesartan | One source FDA |
| DrugBank | DB13919 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.